These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
806 related articles for article (PubMed ID: 11395238)
1. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Eisbruch A; Kim HM; Terrell JE; Marsh LH; Dawson LA; Ship JA Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):695-704. PubMed ID: 11395238 [TBL] [Abstract][Full Text] [Related]
2. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Lin A; Kim HM; Terrell JE; Dawson LA; Ship JA; Eisbruch A Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):61-70. PubMed ID: 12909216 [TBL] [Abstract][Full Text] [Related]
3. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. Eisbruch A; Ship JA; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Hogikyan ND; Anzai Y; Marsh LH; Ten Haken RK; Wolf GT World J Surg; 2003 Jul; 27(7):832-7. PubMed ID: 14509515 [TBL] [Abstract][Full Text] [Related]
4. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Henson BS; Inglehart MR; Eisbruch A; Ship JA Oral Oncol; 2001 Jan; 37(1):84-93. PubMed ID: 11120488 [TBL] [Abstract][Full Text] [Related]
5. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Eisbruch A; Ship JA; Martel MK; Ten Haken RK; Marsh LH; Wolf GT; Esclamado RM; Bradford CR; Terrell JE; Gebarski SS; Lichter AS Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):469-80. PubMed ID: 8892473 [TBL] [Abstract][Full Text] [Related]
6. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231 [TBL] [Abstract][Full Text] [Related]
7. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study. Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262 [TBL] [Abstract][Full Text] [Related]
8. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Eisbruch A; Ten Haken RK; Kim HM; Marsh LH; Ship JA Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):577-87. PubMed ID: 10524409 [TBL] [Abstract][Full Text] [Related]
9. Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life. Hawkins PG; Lee JY; Mao Y; Li P; Green M; Worden FP; Swiecicki PL; Mierzwa ML; Spector ME; Schipper MJ; Eisbruch A Radiother Oncol; 2018 Jan; 126(1):68-74. PubMed ID: 28823405 [TBL] [Abstract][Full Text] [Related]
10. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands. Little M; Schipper M; Feng FY; Vineberg K; Cornwall C; Murdoch-Kinch CA; Eisbruch A Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1007-14. PubMed ID: 22056067 [TBL] [Abstract][Full Text] [Related]
11. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418 [TBL] [Abstract][Full Text] [Related]
12. Radiation-induced Xerostomia is Related to Stem Cell Dose-dependent Reduction of Saliva Production. van Rijn-Dekker MI; la Bastide-van Gemert S; Stokman MA; Vissink A; Coppes RP; Langendijk JA; van Luijk P; Steenbakkers RJHM Int J Radiat Oncol Biol Phys; 2024 Nov; 120(3):772-782. PubMed ID: 38631537 [TBL] [Abstract][Full Text] [Related]
13. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing. Rosenthal DI; Chambers MS; Weber RS; Eisbruch A Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519 [TBL] [Abstract][Full Text] [Related]
14. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436 [TBL] [Abstract][Full Text] [Related]
16. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Saarilahti K; Kouri M; Collan J; Kangasmäki A; Atula T; Joensuu H; Tenhunen M Radiother Oncol; 2006 Mar; 78(3):270-5. PubMed ID: 16564589 [TBL] [Abstract][Full Text] [Related]
17. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer]. Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220 [TBL] [Abstract][Full Text] [Related]
18. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Eisbruch A; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Anzai Y; Marsh LH; Martel MK; Ten Haken RK; Wolf GT; Ship JA Acta Otorhinolaryngol Belg; 1999; 53(3):271-5. PubMed ID: 10635407 [TBL] [Abstract][Full Text] [Related]
19. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up. Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726 [TBL] [Abstract][Full Text] [Related]
20. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy. Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]